FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to experimental surgery, and can be used for modelling aseptic peritonitis. Mice are administered intraperitoneally a solution containing nano-sized metal particles obtained from dental implants, an antibiotic Bicillin-5, a lipopolysaccharide from E.Coli O111:B4 and water in form of bidistol as a solvent.
EFFECT: method enables preparing a pathophysiological model of aseptic peritonitis to confirm the ability of diffusion of metal-containing nanoparticles from the surface of dental implants and their ability to migrate into immunocompetent organs with background of inflammatory processes in the living body.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING INFECTIOUS PERITONITIS EXPERIMENTALLY | 2014 |
|
RU2553342C1 |
METHOD FOR SIMULATING EXPERIMENTAL AMYLOID DISEASE IN ANIMALS | 2014 |
|
RU2572721C1 |
METHOD FOR AUTOTRANSPLANTATION OF SPLENIC TISSUES | 1994 |
|
RU2112429C1 |
METHOD FOR PRODUCING AGENT FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE LOW-MOLECULAR NANOPARTICLE-BASED COMPOUNDS | 2014 |
|
RU2557987C1 |
METHOD FOR INTRODUCING GOLD NANOPARTICLES BY LOCAL SKIN APPLICATION | 2012 |
|
RU2500381C1 |
AGENT FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY HIGH-MOLECULAR COMPOUND OF NANOPARTICLES AND METHOD FOR PREPARING IT | 2014 |
|
RU2541121C1 |
METHOD OF PERSONALISED SELECTION OF DENTAL IMPLANT BASED ON TITANIUM OXIDE ALLOYS | 2015 |
|
RU2611013C1 |
INTERPOLYMER POLYELECTROLYTE COMPLEX AND A PROLONGED IMMUNOSTIMULATING AGENT ON ITS BASIS, FOR MEDICAL AND VETERINARY USE | 2017 |
|
RU2683947C1 |
IMMUNOBIOLOGICAL AGENT TO ENHANCE CELLULAR RESPONSE AGAINST HEPATITIS C VIRUS | 2023 |
|
RU2811136C1 |
METHOD OF RESTORING MYELOID TISSUE OF OLD LABORATORY ANIMALS AFTER INFLUENCE OF IONISING IRRADIATION | 2008 |
|
RU2394585C1 |
Authors
Dates
2020-12-04—Published
2018-07-13—Filed